Literature DB >> 33225405

Myotoxic drugs and immunodeficiency may contribute to the poor outcome of COVID-19 patients with myotonic dystrophy.

J Finsterer1.   

Abstract

Entities:  

Keywords:  Brain; COVID-19; Encephalitis; MRI; SARS-CoV-2

Year:  2020        PMID： 33225405      PMCID： PMC7680670          DOI： 10.1007/s13760-020-01551-8

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN： 0300-9009            Impact factor:   2.396


× No keyword cloud information.
  5 in total

1.  [Occurrence of chloroquine-induced myopathy after low-dose treatment of rheumatoid arthritis for seven years].

Authors:  A Haberl; P Fischer; D Pongratz; J P Sieb
Journal:  Z Rheumatol       Date:  2005-05       Impact factor: 1.372

2.  Myalgia and swelling of interphalangeal joints as side-effect of prolonged azithromycin therapy in patient with pelvic actinomycosis: case report.

Authors:  Bosko Desnica; Antun Beus; Tomislava Skuhala; Mirjana Balen Topic; Nina Vickovic; Nikola Makek
Journal:  Scand J Infect Dis       Date:  2007

3.  Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction.

Authors:  Johanna Strandell; Andrew Bate; Staffan Hägg; I Ralph Edwards
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

Review 4.  Negative nasopharyngeal swabs in COVID-19 pneumonia: the experience of an Italian Emergengy Department (Piacenza) during the first month of the Italian epidemic.

Authors:  Erika Poggiali; Andrea Vercelli; Giovanni Battista Vadacca; Roberta Schiavo; Silvana Mazzoni; Eva Ioannilli; Elena Demichele; Andrea Magnacavallo
Journal:  Acta Biomed       Date:  2020-09-07

5.  Myotonic dystrophy type 1 as a major risk factor for severe COVID-19?

Authors:  Sebastiaan Dhont; Rutger Callens; Dieter Stevens; Fre Bauters; Jan L De Bleecker; Eric Derom; Eva Van Braeckel
Journal:  Acta Neurol Belg       Date:  2020-10-14       Impact factor: 2.396
  5 in total
  1 in total

1.  Discrepancy between Mild Muscle Pathology and Severe Muscular Compromise in COVID-19 Suggests Nonviral Etiologies.

Authors:  Josef Finsterer; Liam Chen
Journal:  J Neuropathol Exp Neurol       Date:  2021-11-19       Impact factor: 3.685
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.